Susquehanna International Group
KNSA icon

Susquehanna International Group’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Susquehanna International Group’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$612K Sell
12,700
-42,900
-77% -$1.9M ﹤0.01% 9138
2025
Q4 		$2.29M Sell
55,600
-35,200
-39% -$1.41M ﹤0.01% 5353
2025
Q3 		$3.53M Buy
+90,800
New +$2.95M ﹤0.01% 4677
2025
Q1 		– Sell
-55,700
Closed -$1.1M – 13012
2024
Q4 		$1.1M Sell
55,700
-1,100
-2% -$25.1K ﹤0.01% 6714
2024
Q3 		$1.42M Sell
56,800
-5,400
-9% -$132K ﹤0.01% 6030
2024
Q2 		$1.16M Sell
62,200
-69,600
-53% -$1.3M ﹤0.01% 6234
2024
Q1 		$2.6M Buy
131,800
+39,500
+43% +$771K ﹤0.01% 4791
2023
Q4 		$1.62M Buy
92,300
+48,600
+111% +$799K ﹤0.01% 5821
2023
Q3 		$759K Buy
43,700
+23,900
+121% +$403K ﹤0.01% 7266
2023
Q2 		$279K Buy
+19,800
New +$265K ﹤0.01% 9591
2023
Q1 		– Sell
-19,800
Closed -$297K – 13070
2022
Q4 		$297K Sell
19,800
-87,100
-81% -$1.27M ﹤0.01% 9127
2022
Q3 		$1.37M Buy
106,900
+40,100
+60% +$457K ﹤0.01% 5804
2022
Q2 		$647K Buy
66,800
+42,000
+169% +$392K ﹤0.01% 7635
2022
Q1 		$247K Sell
24,800
-54,000
-69% -$572K ﹤0.01% 10745
2021
Q4 		$927K Sell
78,800
-11,300
-13% -$139K ﹤0.01% 7506
2021
Q3 		$1.03M Sell
90,100
-15,800
-15% -$206K ﹤0.01% 7498
2021
Q2 		$1.48M Buy
105,900
+37,600
+55% +$571K ﹤0.01% 6688
2021
Q1 		$1.26M Sell
68,300
-4,200
-6% -$85.9K ﹤0.01% 7102
2020
Q4 		$1.28M Buy
72,500
+57,000
+368% +$1M ﹤0.01% 6094
2020
Q3 		$237K Sell
15,500
-14,200
-48% -$267K ﹤0.01% 9173
2020
Q2 		$757K Buy
+29,700
New +$620K ﹤0.01% 6501

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Susquehanna International Group's KNSA Position: Q1 2026 in Review

Susquehanna International Group increased its Kiniksa Pharmaceuticals (KNSA) stake by 795% in Q1 2026, buying an estimated $15.1M and bringing the position to 383,811 shares worth $18.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2333.

Susquehanna International Group first reported a position in KNSA in Q3 2020 and has held it in 21 quarters since. 228 funds tracked by Wall St. Rank hold KNSA as of Q1 2026.

  • Susquehanna International Group held 383,811 shares of Kiniksa Pharmaceuticals worth $18.5M as of Q1 2026.
  • Susquehanna International Group bought 340,914 Kiniksa Pharmaceuticals shares in Q1 2026, an estimated $15.1M.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2333 holding.
  • Susquehanna International Group first reported a position in Kiniksa Pharmaceuticals in Q3 2020 and has held it in 21 quarters since.
  • 228 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.